Pfizer bids $100B deal for AstraZeneca

Pfizer bids $100B deal for AstraZeneca

Reuters: The U.S. drugmaker hopes to takeover Britain's AstraZeneca Plc.

Pfizer said on Monday it made a 58.8 billion pounds ($98.9 billion) bid approach to AstraZeneca in January and had contacted its British rival again on April 26, seeking to further discuss a takeover.

Buying AstraZeneca would boost Pfizer's pipeline of cancer drugs and create significant cost and tax savings.

Read more here.